Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Raw Materials (2016 - 2025)

STRATA Skin Sciences' Raw Materials history spans 11 years, with the latest figure at $2.6 million for Q4 2025.

  • On a quarterly basis, Raw Materials rose 27.44% to $2.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.6 million, a 27.44% increase, with the full-year FY2025 number at $2.6 million, up 27.44% from a year prior.
  • Raw Materials hit $2.6 million in Q4 2025 for STRATA Skin Sciences, down from $2.9 million in the prior quarter.
  • Over the last five years, Raw Materials for SSKN hit a ceiling of $5.8 million in Q3 2023 and a floor of $2.0 million in Q4 2024.
  • Historically, Raw Materials has averaged $3.4 million across 5 years, with a median of $2.9 million in 2022.
  • Biggest five-year swings in Raw Materials: surged 79.43% in 2022 and later tumbled 58.53% in 2024.
  • Tracing SSKN's Raw Materials over 5 years: stood at $3.2 million in 2021, then dropped by 7.34% to $3.0 million in 2022, then decreased by 26.1% to $2.2 million in 2023, then dropped by 6.89% to $2.0 million in 2024, then rose by 27.44% to $2.6 million in 2025.
  • Business Quant data shows Raw Materials for SSKN at $2.6 million in Q4 2025, $2.9 million in Q3 2025, and $3.2 million in Q2 2025.